Table 2.

Results summary for the primary tumors LNs

Primary Tumors
Patient #	FDG MTV	Blood SUV	FDG SUVmax	FDG SUVavg	FMISO SUVmax	FMISO SUVavg	FDG SUVavg (T/B > 1.2)	FMISO SUVmax (T/B > 1.2)	FMISO SUVavg (T/B > 1.2)	HV	HF	R	R (T/B > 1.2)	FDG SUVmax within FMISO HV2
1	13.01	N/A	17.33	10.54	2.88	2.02	–	–	–	NBD5	–	0.66	–	N
2	16.82	1.52	12.72	7.64	3.69	2.09	8.13	3.69	2.41	11.30	67.21	0.49	0.31	Y
3	NFU6	–	–	–	–	–	–	–	–	–	–	–	–	Y
4	4.21	1.38	7.62	4.83	1.86	1.38	6.52	1.86	1.74	0.56	13.28	0.57	0.64	Y
5	12.89	2.10	32.24	19.08	3.69	2.52	22.33	3.69	2.98	6.23	48.34	0.70	0.46	Y
6	7.67	1.49	13.67	7.99	3.20	2.08	8.66	3.20	2.30	5.59	72.90	0.68	0.48	Y
7	8.82	1.63	8.53	5.10	2.33	1.61	5.84	2.33	2.07	1.22	13.79	0.36	NSS7	N
8	16.38	1.33	17.65	9.33	3.74	2.33	9.45	3.74	2.38	15.44	94.24	0.60	0.59	Y
9	34.88	1.52	13.71	8.72	3.22	1.92	9.34	3.22	2.15	21.23	60.86	0.50	0.34	Y
10	8.43	0.72	23.43	12.78	2.43	1.81	12.78	2.43	1.81	8.43	100.00	0.70	0.70	Y
11*	4.04	1.58	10.18	5.15	2.06	1.50	7.18	2.06	1.96	0.29	7.27	0.31	0.42	N
12	3.89	1.53	11.95	6.86	2.71	1.67	8.74	2.71	2.04	0.98	25.11	0.62	0.32	N
13	4.29	1.34	17.73	9.64	2.91	2.08	9.90	2.91	2.14	3.88	90.40	0.52	0.48	Y
14	5.27	1.20	12.47	8.24	2.44	1.82	8.41	2.44	1.86	4.87	92.24	0.72	0.71	Y
15	6.04	0.92	12.43	7.09	2.47	1.63	7.11	2.47	1.63	6.00	99.22	0.72	0.71	Y
16	8.90	1.28	13.15	8.07	2.49	1.93	8.09	2.49	1.94	8.86	99.58	0.59	0.59	Y
17	11.56	2.04	12.61	6.95	2.91	2.30	9.80	2.91	2.58	2.17	18.75	0.81	0.52	Y
18	7.58	1.09	16.38	8.10	2.00	1.60	8.35	2.00	1.63	6.66	87.90	0.18	0.05	Y
19	4.36	1.88	10.07	5.33	2.29	1.57	6.36	2.29	2.27	0.01	0.28	0.31	NSS	N
20	10.74	1.23	11.50	6.37	3.97	1.93	6.44	3.97	2.01	9.57	89.07	0.11	0.05	Y

MTV = Metabolic Tumor Volume

HV = Hypoxic Volume

HF = Hypoxic Fraction

R = Pearson Correlation Coefficient

NBD = No Blood Data

NFU = No FDG Uptake

NSS = Not statistically significant

* = Statistical outlier

(T/B > 1.2) = Only analyzed for voxels that have SUV's greater than 1.2 × SUV of Blood